Empatica
Private Company
Funding information not available
Overview
Empatica, founded in 2013 and headquartered in Milan, Italy, is a commercial-stage digital health company specializing in medical-grade wearable technology and AI-driven digital biomarkers. Its core offering is the Empatica Health Monitoring Platform, an FDA-cleared and CE-certified system that enables remote, continuous collection of clinical-quality data from daily life. The company has established a strong position in neurology with cleared devices for epilepsy monitoring and Parkinson's disease, and its platform is widely adopted by pharmaceutical companies for clinical trials and academic research. Empatica's business model is built on providing hardware, software, and data analytics as a diagnostics and monitoring service.
Technology Platform
FDA-cleared and CE-certified full-stack health monitoring platform comprising medical-grade wearable sensors (e.g., EmbracePlus, EmbraceMini), continuous cloud data collection, and AI algorithms generating a library of over 300 digital biomarkers from physiological data like EDA, PPG, and motion.
Opportunities
Risk Factors
Competitive Landscape
Empatica competes in the medical-grade wearable and digital biomarker space. Key competitors include dedicated neurology-focused companies like BioSerenity, as well as broader RPM players such as Philips and Medtronic. Tech giants like Apple (with its FDA-cleared AFib feature) also represent competitive pressure. Empatica's differentiation lies in its depth of neurological clearances, its large library of proprietary digital biomarkers, and its end-to-end, regulatory-approved platform tailored for clinical research and care.